{"count": 5, "results": [{"_id": "40694905", "pmid": 40694905, "title": "Cardioprotective effect of metformin/donepezil combination in HFD/STZ-induced diabetic male Wistar rats involves acetylcholinesterase inhibition and modulation of Bax/Bcl-2/caspase 3 pathway.", "journal": "Biochem Biophys Res Commun", "authors": ["Saka WA", "Olamoyegun MA", "Ashonibare VJ", "Ashonibare PJ", "Oladipo AA", "Adegbola CA", "Kolawole OR", "Adeyeni AE", "Akinkunmi OA", "Adebayo J", "Akhigbe TM", "Akhigbe RE"], "date": "2025-07-18T00:00:00Z", "doi": "10.1016/j.bbrc.2025.152386", "meta_date_publication": "2025 Jul 18", "meta_volume": "778", "meta_issue": "", "meta_pages": "152386", "score": 50240.316, "text_hl": "Also, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Donepezil @CHEMICAL_MESH:D000077265 @@@donepezil@@@ reduced the damage caused by @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ to the heart, including high levels of injury markers, @DISEASE_Soft_Tissue_Injuries @DISEASE_MESH:D017695 @@@tissue damage@@@, and @<m>DISEASE_AA_amyloidosis</m> @DISEASE_MESH:C000718787 @@@amyloid@@@ buildup. ", "citations": {"NLM": "Saka WA, Olamoyegun MA, Ashonibare VJ, Ashonibare PJ, Oladipo AA, Adegbola CA, Kolawole OR, Adeyeni AE, Akinkunmi OA, Adebayo J, Akhigbe TM, Akhigbe RE. Cardioprotective effect of metformin/donepezil combination in HFD/STZ-induced diabetic male Wistar rats involves acetylcholinesterase inhibition and modulation of Bax/Bcl-2/caspase 3 pathway. Biochem Biophys Res Commun. 2025 Jul 18;778():152386. PMID: 40694905", "BibTeX": "@article{40694905, title={Cardioprotective effect of metformin/donepezil combination in HFD/STZ-induced diabetic male Wistar rats involves acetylcholinesterase inhibition and modulation of Bax/Bcl-2/caspase 3 pathway.}, author={Saka WA and Olamoyegun MA and Ashonibare VJ and Ashonibare PJ and Oladipo AA and Adegbola CA and Kolawole OR and Adeyeni AE and Akinkunmi OA and Adebayo J and Akhigbe TM and Akhigbe RE}, journal={Biochem Biophys Res Commun}, volume={778}, pages={152386}}"}}, {"_id": "40296752", "pmid": 40296752, "title": "Hybrid Lipoplex Boosts Neuron-Microglia Crosstalk for Treatment of Alzheimer's Disease through Abeta-Targeted-Autophagy and ApoE2 Gene Supplementation.", "journal": "Adv Mater", "authors": ["Pu Y", "Dai XL", "Wang Y", "Chen Y", "Wu C", "Zhou X", "Chen M", "Chen YH", "Shuai X", "Jin R", "Nie Y"], "date": "2025-04-29T00:00:00Z", "doi": "10.1002/adma.202418560", "meta_date_publication": "2025 Apr 29", "meta_volume": "", "meta_issue": "", "meta_pages": "e2418560", "score": 50231.18, "text_hl": "Herein, @CHEMICAL_Guanidine @CHEMICAL_MESH:D019791 @@@guanidine@@@-rich @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipids@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-inspired MLS and @CHEMICAL_Arginine @CHEMICAL_MESH:D001120 @@@arginine@@@-contained RLS) are devised to trigger selective chaperone-mediated autophagy for @<m>DISEASE_AA_amyloidosis</m> @DISEASE_MESH:C000718787 @@@amyloid@@@ precursor protein degradation in neurons. ", "citations": {"NLM": "Pu Y, Dai XL, Wang Y, Chen Y, Wu C, Zhou X, Chen M, Chen YH, Shuai X, Jin R, Nie Y. Hybrid Lipoplex Boosts Neuron-Microglia Crosstalk for Treatment of Alzheimer's Disease through Abeta-Targeted-Autophagy and ApoE2 Gene Supplementation. Adv Mater. 2025 Apr 29;():e2418560. PMID: 40296752", "BibTeX": "@article{40296752, title={Hybrid Lipoplex Boosts Neuron-Microglia Crosstalk for Treatment of Alzheimer's Disease through Abeta-Targeted-Autophagy and ApoE2 Gene Supplementation.}, author={Pu Y and Dai XL and Wang Y and Chen Y and Wu C and Zhou X and Chen M and Chen YH and Shuai X and Jin R and Nie Y}, journal={Adv Mater}, pages={e2418560}}"}}, {"_id": "40622910", "pmid": 40622910, "title": "Breaking the vicious cycle: bitter compounds targeting metabolic defects and inflammation in Alzheimer's disease.", "journal": "Am J Physiol Endocrinol Metab", "authors": ["Wu H", "He L", "Dai L"], "date": "2025-08-01T00:00:00Z", "doi": "10.1152/ajpendo.00166.2025", "meta_date_publication": "2025 Aug 1", "meta_volume": "329", "meta_issue": "2", "meta_pages": "E266-E275", "score": 50227.348, "text_hl": "Preclinical studies have demonstrated their ability to suppress @DISEASE_Neuroinflammatory_Diseases @DISEASE_MESH:D000090862 @@@neuroinflammation@@@, restore @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity, and mitigate @<m>DISEASE_AA_amyloidosis</m> @DISEASE_MESH:C000718787 @@@amyloid@@@/@GENE_MAPT @GENE_4137 @@@tau@@@ pathology, potentially disrupting the metabolic-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ cycle. ", "citations": {"NLM": "Wu H, He L, Dai L. Breaking the vicious cycle: bitter compounds targeting metabolic defects and inflammation in Alzheimer's disease. Am J Physiol Endocrinol Metab. 2025 Aug 1;329(2):E266-E275. PMID: 40622910", "BibTeX": "@article{40622910, title={Breaking the vicious cycle: bitter compounds targeting metabolic defects and inflammation in Alzheimer's disease.}, author={Wu H and He L and Dai L}, journal={Am J Physiol Endocrinol Metab}, volume={329}, number={2}, pages={E266-E275}}"}}, {"_id": "30251898", "pmid": 30251898, "pmcid": "PMC6161601", "title": "Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation", "journal": "J Enzyme Inhib Med Chem", "authors": ["Markowicz-Piasecka M", "Huttunen KM", "Sikora J"], "date": "2018-12-01T00:00:00Z", "doi": "10.1080/14756366.2018.1499627", "meta_date_publication": "2018 Dec", "meta_volume": "33", "meta_issue": "1", "meta_pages": "1309-1322", "score": 50068.457, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and its @CHEMICAL_Sulfonamides @CHEMICAL_MESH:D013449 @@@sulphonamide@@@ derivative simultaneously potentiateanti-@GENE_BCHE @GENE_590 @@@cholinesterase@@@ activity of @CHEMICAL_Donepezil @CHEMICAL_MESH:D000077265 @@@donepezil@@@ and inhibit @<m>DISEASE_AA_amyloidosis</m> @DISEASE_MESH:C000718787 @@@beta-amyloid aggregation@@@", "citations": {"NLM": "Markowicz-Piasecka M, Huttunen KM, Sikora J. Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation J Enzyme Inhib Med Chem. 2018 Dec;33(1):1309-1322. PMID: 30251898", "BibTeX": "@article{30251898, title={Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation}, author={Markowicz-Piasecka M and Huttunen KM and Sikora J}, journal={J Enzyme Inhib Med Chem}, volume={33}, number={1}, pages={1309-1322}}"}}, {"_id": "22000494", "pmid": 22000494, "title": "Metformin effects revisited.", "journal": "Diabetes Res Clin Pract", "authors": ["Andújar-Plata P", "Pi-Sunyer X", "Laferrère B"], "date": "2012-01-01T00:00:00Z", "doi": "10.1016/j.diabres.2011.09.022", "meta_date_publication": "2012 Jan", "meta_volume": "95", "meta_issue": "1", "meta_pages": "1-9", "score": 50063.2, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ effects revisited.", "citations": {"NLM": "Andújar-Plata P, Pi-Sunyer X, Laferrère B. Metformin effects revisited. Diabetes Res Clin Pract. 2012 Jan;95(1):1-9. PMID: 22000494", "BibTeX": "@article{22000494, title={Metformin effects revisited.}, author={Andújar-Plata P and Pi-Sunyer X and Laferrère B}, journal={Diabetes Res Clin Pract}, volume={95}, number={1}, pages={1-9}}"}}]}